Understanding COVID-19 Testing Knowledge and Practices Among 2-1-1 Helpline Callers

Communication Clinical Trial

Official title:

Rapid Acceleration of Diagnostics Underserved Populations Supplement: Understanding COVID-19 Testing Knowledge and Practices Among 2-1-1 Helpline Callers

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05812599
• Other study ID #: 3R01CA235773-03S1
• Status: Completed
• Phase: N/A
• Start date: September 22, 2022
• Est. completion date: January 20, 2023

Study information

• Verified date: April 2023
• Source: Washington University School of Medicine
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to identify promising health education strategies and culturally appropriate messages for use by 2-1-1 practitioners to promote coronavirus disease of 2019 (COVID) testing behaviors. Previous study findings and evidence-based health communication and education tactics were integrated to create an interactive learning module that includes four narrative scenarios, illustrations, and accompanying questions and responses that inform the audience about COVID testing guidelines. The study will test the effectiveness of the interactive learning module with 2-1-1 callers (n=300) in Connecticut, North Carolina, and Nebraska. Participants' contact information will be shared with us by 2-1-1 with the participants' given consent. The study team will send the potential participant via text message a link to a survey that includes a screen where they will provide informed consent. Those who provide consent will be randomly assigned to receive one of two surveys. The inclusion of the interactive learning module is what varies across the surveys. An experimental group will receive the learning module with a study team-developed pre- and post-survey, and the control group will receive only the study team-developed pre- and post-survey. The post-survey contains questions regarding information covered in the interactive learning module. It is hypothesized that those who complete the interactive learning module in the experimental group will score better on the post-survey questions when compared to the control group. All participants, regardless of experimental or control condition, will receive an information sheet with the most up-to-date scientific guidelines for COVID testing.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 298
• Est. completion date: January 20, 2023
• Est. primary completion date: January 20, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Individuals who called 211 in Connecticut, Nebraska, or North Carolina on behalf of themselves or their families
• Must be 18 or older
• Must have English language proficiency
• Must be willing to be contacted via text messages or email

Exclusion Criteria:

• N/A

Related Conditions & MeSH terms

• Communication
• Health Knowledge, Attitudes, Practice

Intervention

Other:
• Educational Module
The COVID Test Learning Module will present four multi-part character scenarios that someone might experience when considering testing for COVID-19. Participants will answer questions about the character's behavior. Accurate guidelines will be provided in response to each scenario to educate participants about what to do in nuanced COVID testing decision-making situations.

Locations

Country	Name	City	State
United States	Washington University in St. Louis	Saint Louis	Missouri

Sponsors (1)

Lead Sponsor	Collaborator
Washington University School of Medicine

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Proportion of participants who answer post-test questions correctly	The primary objective of this study is to evaluate differences in knowledge regarding COVID testing between 2-1-1 callers randomized to the control vs. experimental group. Participants who do better would answer more items correctly on the COVID prevention knowledge post-test. Assessed using a non-parametric t-test.	Through survey completion, an average of 10-15 minutes.
Secondary	Number of participants with knowledge gained after exposure to learning module	A secondary outcome is to identify if exposure to the learning module increased participant knowledge about COVID prevention. Assessed by comparing the percentage of correct answers from questions within the learning module to the percentage of correct answers in the post-test.	Through survey completion, an average of 10-15 minutes.